BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 27416795)

  • 1. Adherence patterns to National Comprehensive Cancer Network (NCCN) guidelines for referral to cancer genetic professionals.
    Febbraro T; Robison K; Wilbur JS; Laprise J; Bregar A; Lopes V; Legare R; Stuckey A
    Gynecol Oncol; 2015 Jul; 138(1):109-14. PubMed ID: 25933682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. No Racial Disparities Observed Using Point-of-Care Genetic Counseling and Testing for Endometrial and Ovarian Cancer in a Diverse Patient Population: A Retrospective Cohort Study.
    Kim M; Hayek J; Acker C; An A; Zhang P; Gorelick C; Kanis MJ
    Cancers (Basel); 2024 Apr; 16(8):. PubMed ID: 38672679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A pilot randomized controlled study to determine the effectiveness of video educational tool in BRCA1/2 pre-test counseling for Japanese breast cancer patients.
    Nakamura H; Morinaga S; Tsuchiya K; Sakoda Y; Ogino M; Ueno S; Tanino H; Kunihisa T
    J Genet Couns; 2024 Jun; ():. PubMed ID: 38852990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hereditary breast and ovarian cancer: successful systematic implementation of a group approach to genetic counselling.
    Benusiglio PR; Di Maria M; Dorling L; Jouinot A; Poli A; Villebasse S; Le Mentec M; Claret B; Boinon D; Caron O
    Fam Cancer; 2017 Jan; 16(1):51-56. PubMed ID: 27624814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A qualitative feasibility study of a prototype patient-centered video intervention to increase uptake of cancer genetic testing among Black Americans.
    Smith KC; Grob R; McCullough M; May B; Warne E; Matchette A; Connor AE; Visvanathan K
    Pilot Feasibility Stud; 2024 Apr; 10(1):62. PubMed ID: 38605397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The ENGAGE study: evaluation of a conversational virtual agent that provides tailored pre-test genetic education to cancer patients.
    Visvanathan K; Petry D; McCullough MS; May B; Tenkasi R; Sharma N; Klein CA; Johnson A; Killian G; Camp M; Paller CJ; Couzi R; Wilkinson M; Jacobs L; Lange J; Jelovac D; Carducci MA; Habibi M; Naik G; Kotwaliwale A
    J Cancer Surviv; 2023 Dec; ():. PubMed ID: 38064163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pretest Video Education Versus Genetic Counseling for Patients With Prostate Cancer: ProGen, A Multisite Randomized Controlled Trial.
    Rana HQ; Stopfer JE; Weitz M; Kipnis L; Koeller DR; Culver S; Mercado J; Gelman RS; Underhill-Blazey M; McGregor BA; Sweeney CJ; Petrucelli N; Kokenakes C; Pirzadeh-Miller S; Reys B; Frazier A; Knechtl A; Fateh S; Vatnick DR; Silver R; Kilbridge KE; Pomerantz MM; Wei XX; Choudhury AD; Sonpavde GP; Kozyreva O; Lathan C; Horton C; Dolinsky JS; Heath EI; Ross TS; Courtney KD; Garber JE; Taplin ME
    JCO Oncol Pract; 2023 Nov; 19(11):1069-1079. PubMed ID: 37733980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic counseling and testing for females at elevated risk for breast cancer: Protocol for the randomized controlled trial of the Know Your Risk intervention.
    Sweet K; Reiter PL; Schnell PM; Senter L; Shane-Carson KP; Aeilts A; Cooper J; Spears C; Brown J; Toland AE; Agnese DM; Katz ML
    Contemp Clin Trials; 2023 Oct; 133():107323. PubMed ID: 37661005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Uptake of Genetic Research Results and Patient-Reported Outcomes With Return of Results Incorporating Web-Based Predisclosure Education.
    Kilbride M; Egleston BL; Chung WK; Olopade O; Maxwell KN; Shah P; Churpek JE; Fleisher L; Terry MB; Fetzer D; Gaieski JB; Bulafka J; Espinal A; Karpink K; Walser S; Singleton D; Palese M; Siljander I; Brandt A; Clark D; Koval C; Wynn J; Long JM; McKenna D; Powers J; Nielsen S; Domchek SM; Nathanson KL; Bradbury AR
    J Clin Oncol; 2023 Nov; 41(31):4905-4915. PubMed ID: 37611220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patient decision support resources inform decisions about cancer susceptibility genetic testing and risk management: a systematic review of patient impact and experience.
    Kohut K; Morton K; Turner L; Shepherd J; Fenerty V; Woods L; Grimmett C; Eccles DM; Foster C
    Front Health Serv; 2023; 3():1092816. PubMed ID: 37395995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Barriers, interventions, and recommendations: Improving the genetic testing landscape.
    Dusic EJ; Theoryn T; Wang C; Swisher EM; Bowen DJ;
    Front Digit Health; 2022; 4():961128. PubMed ID: 36386046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An overview of genetic services delivery for hereditary breast cancer.
    Reid S; Spalluto LB; Lang K; Weidner A; Pal T
    Breast Cancer Res Treat; 2022 Feb; 191(3):491-500. PubMed ID: 35079980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors Influencing Patient Preferences for Telehealth Cancer Genetic Counseling During the COVID-19 Pandemic.
    Breen KE; Tuman M; Bertelsen CE; Sheehan M; Wylie D; Fleischut MH; Offit K; Stadler ZK; Salo-Mullen EE; Hamilton JG
    JCO Oncol Pract; 2022 Apr; 18(4):e462-e471. PubMed ID: 34652959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implementation of an Embedded In-Clinic Genetic Testing Station to Optimize Germline Testing for Patients with Pancreatic Adenocarcinoma.
    Walker EJ; Goldberg D; Gordon KM; Pedley C; Carnevale J; Cinar P; Collisson EA; Tempero MA; Ko AH; Blanco AM; Dhawan M
    Oncologist; 2021 Nov; 26(11):e1982-e1991. PubMed ID: 34506673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Achieving universal genetic assessment for women with ovarian cancer: Are we there yet? A systematic review and meta-analysis.
    Lin J; Sharaf RN; Saganty R; Ahsan D; Feit J; Khoury A; Bergeron H; Chapman-Davis E; Cantillo E; Holcomb K; Blank SV; Liu Y; Thomas C; Christos PJ; Wright DN; Lipkin S; Offit K; Frey MK
    Gynecol Oncol; 2021 Aug; 162(2):506-516. PubMed ID: 34023131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Qualitative Methods for Refining a Web-Based Educational Tool for Patients Focused on Inherited Cancer Predisposition.
    Tezak AL; Zuniga B; Weidner A; Cragun D; Pal T
    J Cancer Educ; 2022 Aug; 37(4):1129-1136. PubMed ID: 33400205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Homologous recombination deficiency (HRD) testing in ovarian cancer clinical practice: a review of the literature.
    Frey MK; Pothuri B
    Gynecol Oncol Res Pract; 2017; 4():4. PubMed ID: 28250960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Video-assisted genetic counseling in patients with ovarian, fallopian and peritoneal carcinoma.
    Watson CH; Ulm M; Blackburn P; Smiley L; Reed M; Covington R; Bokovitz L; Tillmanns T
    Gynecol Oncol; 2016 Oct; 143(1):109-112. PubMed ID: 27416795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Timing of referral for genetic counseling and genetic testing in patients with ovarian, fallopian tube, or primary peritoneal carcinoma.
    Novetsky AP; Smith K; Babb SA; Jeffe DB; Hagemann AR; Thaker PH; Powell MA; Mutch DG; Massad LS; Zighelboim I
    Int J Gynecol Cancer; 2013 Jul; 23(6):1016-21. PubMed ID: 23748176
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.